Lettres d'information

Choisissez ce que vous souhaitez recevoir :

Merci de renseigner votre adresse de messagerie électronique :

@

Votre adresse email ne sera utilisée que dans le cadre de campagnes d'information ITER Organization auxquelles vous êtes abonné. ITER Organization ne communiquera jamais votre adresse email et autres informations personnelles à quiconque ou dans le cadre d'informations commerciales.

Si vous changez d'avis, il vous est possible de vous désinscrire en cliquant sur le lien 'unsubscribe' visible dans vos emails provenant d'ITER Organization.

Pour plus d'information, veuillez consulter notre Politique de confidentialité.

Actu & Médias

Links

Of Interest

See archived articles

Conferences


ITER NEWSLINE 241

Pour les actualités en français, voir la page Actus & Médias.

New JET results tick all the boxes for ITER

JET's initial results were summarized by Dr Francesco Romanelli, leader of the European Fusion Development Agreement (EFDA) and JET leader, at the IAEA Fusion Energy Conference in San Diego, US on Monday 8 October. (Click to view larger version...)
JET's initial results were summarized by Dr Francesco Romanelli, leader of the European Fusion Development Agreement (EFDA) and JET leader, at the IAEA Fusion Energy Conference in San Diego, US on Monday 8 October.
Latest results from the Joint European Torus (JET) fusion device are giving researchers increasing confidence in prospects for the next-generation ITER Project, the international experiment that is expected to pave the way for commercial fusion power plants. Operation with a new lining inside, JET has demonstrated the suitability of materials for the much larger and more powerful ITER device.

JET, Europe's premier magnetic confinement fusion facility based at Culham, UK, has completed eleven months of tests to simulate the environment inside ITER and to prototype key components. For this purpose JET has been successfully transformed into a 'mini-ITER' with a wall made of the same materials—beryllium and tungsten—that ITER plans to use.

Read more on the EFDA website.

return to Newsline #241